Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Intranasal Insulin Delivery in Autism Spectrum Disorder Ages 4 to 21 Years (INS-AUT)

NCT07521371 is registered in ClinicalTrials.gov with Healing Hope International as lead sponsor.

NCT NCT07521371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07521371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Intranasal Insulin Delivery in Autism Spectrum Disorder Ages 4 to 21 Years (INS-AUT)
Lead sponsor
Healing Hope International
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2026
Completion date
January 30, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, autism spectrum disorder (asd), autism spectrum disorder high-functioning, autism spectrum disorder with absence of functional language, autism spectrum disorder with impaired functional language, autistic disorder, autistic disorder in children and adolescents, autistic disorder of childhood onset with full syndrome, autistic disorders spectrum, neurodevelopmental disorders, neurodevelopmental disorders (ndd), neurodevelopmental disorders and developmental abnormalities